Evaluating the SERCA2 and VEGF mRNAs as potential molecular biomarkers of the onset and progression in huntington's disease

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Cesca, Federica ^a   Bregant, Elisa ^b   Peterlin, Borut ^c   Zadel, Maja ^c,d   Dubsky De Wittenau, Giorgia ^a   Siciliano, Gabriele ^e   Ceravolo, Roberto ^e   Petrozzi, Lucia ^e   Pauletto, Giada ^a   Verriello, Lorenzo ^a   Bergonzi, Paolo ^a   Damante, Giuseppe ^b   Barillari, Giovanni ^b   Lucci, Bruno ^f   Curcio, Francesco ^a,b   Lonigro, Incoronata Renata ^a,b  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY HOSPITAL OF UDINE   (Italy)

^c UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^d Primary Healthcare Research and Development Institute   (Slovenia)

^e UNIVERSITY OF PISA   (Italy)

^f Azienda Ospedaliera   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; PMCA1 PROTEIN; SARCO ENDOPLASMIC RETICULUM ASSOCIATED ATP2A2 CALCIUM PUMP; SARCO ENDOPLASMIC RETICULUM ASSOCIATED ATP2A3 CALCIUM PUMP; UNCLASSIFIED DRUG; VASCULOTROPIN; ATP2A2 PROTEIN, HUMAN; CALCIUM; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CAG REPEAT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; PERIPHERAL BLOOD MONONUCLEAR CELL; REAL TIME POLYMERASE CHAIN REACTION; DISEASE COURSE; GENETICS; HOMEOSTASIS; HUNTINGTON DISEASE; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; CALCIUM; DISEASE PROGRESSION; FEMALE; HOMEOSTASIS; HUMANS; HUNTINGTON DISEASE; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RNA, MESSENGER; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84928638818     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125259     Document Type: Article

References (62)

1. Vonsattel JP, DiFiglia M. Huntington disease. J Neuropathol Exp Neurol. 1998; 57: 369-384. PMID: 9596408
2. MacDonald ME. Huntingtin: alive and well and working in middle management. Sci STKE 2003; pe48.
3. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993; 72: 971-983. PMID: 8458085
4. Tobin AJ, Signer ER. Huntington's disease: the challenge for cell biologists. Trends Cell Biol. 2000; 10: 531-536. PMID: 11121745
5. Ross CA. Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders. Neuron 2002; 35: 819-822. PMID: 12372277
6. Harjes P, Wanker EE. The hunt for huntingtin function: interaction partners tell many different stories. Trends Biochem Sci. 2003; 28: 425-433. PMID: 12932731
7. Trushina E, Heldebrant MP, Perez-Terzic CM, Bortolon R, Kovtun IV, Badger JD, et al. Microtubule destabilization and nuclear entry are sequential steps leading to toxicity in Huntington's disease. Proc Natl Acad Sci U S A 2003; 100: 12171-12176. PMID: 14527999
8. Sugars KL, Rubinsztein DC. Transcriptional abnormalities in Huntington disease. Trends Genet. 2003; 19: 233-238. PMID: 12711212
9. Bezprozvanny I, Hayden MR. Deranged neuronal calcium signaling and Huntington disease. Biochem Biophys Res Commun. 2004; 322: 1310-1317. PMID: 15336977
10. Cornett J, Cao F, Wang CE, Ross CA, Bates GP, Li SH, et al. Polyglutamine expansion of huntingtin impairs its nuclear export. Nat Genet. 2005; 37: 198-204. PMID: 15654337
11. Li S, Li XJ. Multiple pathways contribute to the pathogenesis of Huntington disease. Mol Neurodegener. 2006; 1: 19. PMID: 17173700
12. Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N, Krainc D. Transcriptional repression of PGC-1 alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 2006; 127: 59-69. PMID: 17018277
13. Trushina E, McMurray CT. Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience 2007; 145: 1233-1248. PMID: 17303344
14. Fan MM, Raymond LA. N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease. Prog Neurobiol. 2007; 81: 272-293. PMID: 17188796
15. Heng MY, Detloff PJ, Wang PL, Tsien JZ, Albin RL. In vivo evidence for NMDA receptor-mediated excitotoxicity in a murine genetic model of Huntington disease. J Neurosci. 2009; 29: 3200-3205. doi: 10.1523/JNEUROSCI.5599-08.2009 PMID: 19279257
16. Roze E, Cahill E, Martin E, Bonnet C, Vanhoutte P, Betuing S, et al. Huntington's Disease and Striatal Signaling. Front Neuroanat. 2011; 5: 55. doi: 10.3389/fnana.2011.00055 PMID: 22007160
17. Marchina E, Misasi S, Bozzato A, Ferraboli S, Agosti C, Rozzini L, et al. Gene expression profile in fibroblasts of Huntington's disease patients and controls. J Neurol Sci. 2014; 337: 42-46. doi: 10.1016/j.jns.2013.11.014 PMID: 24296361
18. Borovecki F, Lovrecic L, Zhou J, Jeong H, Then F, Rosas HD, et al. Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. Proc Natl Acad Sci U S A 2005; 102: 11023-11028. PMID: 16043692
19. Runne H, Kuhn A, Wild EJ, Pratyaksha W, Kristiansen M, Isaacs JD, et al. Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood. Proc Natl Acad Sci U S A 2007; 104: 14424-14429. PMID: 17724341
20. Lovrecic L, Kastrin A, Kobal J, Pirtosek Z, Krainc D, Peterlin B. Gene expression changes in blood as a putative biomarker for Huntington's disease. Mov Disord. 2009; 24: 2277-2281. doi: 10.1002/mds.22477 PMID: 19844910
21. Chang KH, Chen YC, Wu YR, Lee WF, Chen CM. Downregulation of genes involved in metabolism and oxidative stress in the peripheral leukocytes of Huntington's disease patients. PLoSOne 2012; 7: e46492. doi: 10.1371/journal.pone.0046492 PMID: 23029535
22. Sanchez-Lopez F, Tasset I, Aguera E, Feijoo M, Fernandez-Bolanos R, Sánchez FM, et al. Oxidative stress and inflammation biomarkers in the blood of patients with Huntington's disease. Neurol Res. 2012; 34: 721-724. doi: 10.1179/1743132812Y.0000000073 PMID: 22889672
23. Krzyszton-Russjan J, Zielonka D, Jackiewicz J, Kusmirek S, Bubko I, Klimberg A, et al. A study of molecular changes relating to energy metabolism and cellular stress in people with Huntington's disease: looking for biomarkers. J Bioenerg Biomembr. 2013; 45: 71-85. doi: 10.1007/s10863-012-9479-3 PMID: 23070563
24. Diamanti D, Mori E, Incarnato D, Malusa F, Fondelli C, Magnoni L, et al. Whole gene expression profile in blood reveals multiple pathways deregulation in R6/2 mouse model. Biomark Res. 2013; 1: 28. doi: 10.1186/2050-7771-1-28 PMID: 24252798
25. Bezprozvanny I. Calcium signaling and neurodegenerative diseases. Trends Mol Med. 2009; 15: 89-100. doi: 10.1016/j.molmed.2009.01.001 PMID: 19230774
26. Sun Y, Savanenin A, Reddy PH, Liu YF. Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95. J Biol Chem. 2001; 276: 24713-24718. PMID: 11319238
27. Zeron MM, Hansson O, Chen N, Wellington CL, Leavitt BR, Brundin P, et al. Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease. Neuron 2002; 33: 849-860. PMID: 11906693
28. Song C, Zhang Y, Parsons CG, Liu YF. Expression of polyglutamine-expanded huntingtin induces tyrosine phosphorylation of N-methyl-D-aspartate receptors. J Biol Chem. 2003; 278: 33364-33369 PMID: 12810713
29. Shehadeh J, Fernandes HB, Zeron Mullins MM, Graham RK, Leavitt BR, Hayden MR, et al. Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease. Neurobiol Dis. 2006; 21: 392-403. PMID: 16165367
30. Fan MM, Fernandes HB, Zhang LY, Hayden MR, Raymond LA. Altered NMDA receptor trafficking in a yeast artificial chromosome transgenic mouse model of Huntington's disease. J Neurosci. 2007; 27: 3768-3779. PMID: 17409241
31. Tang TS, Tu H, Chan EY, Maximov A, Wang Z, Wellington CL, et al. Huntingtin and huntingtin-associated protein 1 influence neuronal calcium signaling mediated by inositol-(1,4,5) triphosphate receptor type 1. Neuron 2003; 39: 227-239. PMID: 12873381
32. Tang TS, Slow E, Lupu V, Stavrovskaya IG, Sugimori M, Llinás R, et al. Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease. Proc Natl Acad Sci U S A 2005; 102: 2602-2607. PMID: 15695335
33. Czeredys M, Gruszczynska-Biegala J, Schacht T, Methner A, Kuznicki J. Expression of genes encoding the calcium signalosome in cellular and transgenic models of Huntington's disease. Front Mol Neurosci. 2013; 6: 42. doi: 10.3389/fnmol.2013.00042 PMID: 24324398
34. Choi KC, An BS, Yang H, Jeung EB. Regulation and molecular mechanisms of calcium transport genes: do they play a role in calcium transport in the uterine endometrium? J Physiol Pharmacol. 2011; 62: 499-504. PMID: 22204796
35. Prasad V, Okunade G, Liu L, Paul RJ, Shull GE. Distinct phenotypes among plasma membrane Ca2+-ATPase knockout mice. Ann N Y Acad Sci. 2007; 1099: 276-286. PMID: 17446468
36. Gora-Kupilas K, Josko J. The neuroprotective function of vascular endothelial growth factor (VEGF). Folia Neuropathol. 2005; 43: 31-39. PMID: 15827888
37. Ellison SM, Trabalza A, Tisato V, Pazarentzos E, Lee S, Papadaki V, et al. Dose-dependent neuroprotection of VEGF(1)(6)(5) in Huntington's disease striatum. Mol Ther. 2013; 21: 1862-1875. doi: 10.1038/mt.2013.132 PMID: 23799534
38. Baek JH, Jang JE, Kang CM, Chung HY, Kim ND, Kim KW. Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis. Oncogene 2000; 19: 4621-4631. PMID: 11030151
39. Jin K, Mao XO, Batteur SP, McEachron E, Leahy A, Greenberg DA. Caspase-3 and the regulation of hypoxic neuronal death by vascular endothelial growth factor. Neuroscience 2001; 108: 351-358. PMID: 11734367
40. Jin KL, Mao XO, Greenberg DA. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci U S A 2000; 97: 10242-10247. PMID: 10963684
41. Jin K, Zhu Y, Sun Y, Mao XO, Xie L, Greenberg DA. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci U S A 2002; 99: 11946-11950. PMID: 12181492
42. Oosthuyse B, Moons L, Storkebaum E, Beck H, Nuyens D, Brusselmans K, et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet. 2001; 28: 131-138. PMID: 11381259
43. Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, et al. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest. 2003; 111: 1843-1851. PMID: 12813020
44. Volm M, Mattern J, Koomagi R. Inverse correlation between apoptotic (Fas ligand, caspase-3) and angiogenic factors (VEGF, microvessel density) in squamous cell lung carcinomas. Anticancer Res. 1999; 19: 1669-1671. PMID: 10470099
45. Zhu Y, Jin K, Mao XO, Greenberg DA. Vascular endothelial growth factor promotes proliferation of cortical neuron precursors by regulating E2F expression. Faseb j. 2003; 17: 186-193. PMID: 12554697
46. Boyle PJ, Kempers SF, O'Connor AM, Nagy RJ. Brain glucose uptake and unawareness of hypoglycemia in patients with insulin-dependent diabetes mellitus. N Engl J Med. 1995; 333: 1726-1731. PMID: 7491135
47. Dantz D, Bewersdorf J, Fruehwald-Schultes B, Kern W, Jelkmann W, Born J, et al. Vascular endothelial growth factor: a novel endocrine defensive response to hypoglycemia. J Clin Endocrinol Metab. 2002; 87: 835-840. PMID: 11836329
48. Esser S, Wolburg K, Wolburg H, Breier G, Kurzchalia T, Risau W. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol. 1998; 140: 947-959. PMID: 9472045
49. Issa R, Krupinski J, Bujny T, Kumar S, Kaluza J, Kumar P. Vascular endothelial growth factor and its receptor, KDR, in human brain tissue after ischemic stroke. Lab Invest. 1999; 79: 417-425. PMID: 10211994
50. Kumagai AK, Kang YS, Boado RJ, Pardridge WM. Upregulation of blood-brain barrier GLUT1 glucose transporter protein and mRNA in experimental chronic hypoglycemia. Diabetes 1995; 44: 1399-1404. PMID: 7589845
51. Nishie A, Ono M, Shono T, Fukushi J, Otsubo M, Onoue H, et al. Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. Clin Cancer Res. 1999; 5: 1107-1113. PMID: 10353745
52. Pekala P, Marlow M, Heuvelman D, Connolly D. Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-alpha, but not by insulin. J Biol Chem. 1990; 265: 18051-18054. PMID: 2211680
53. Sone H, Deo BK, Kumagai AK. Enhancement of glucose transport by vascular endothelial growth factor in retinal endothelial cells. Invest Ophthalmol Vis Sci. 2000; 41: 1876-1884. PMID: 10845612
54. Warner JP, Barron LH, Brock DJ. A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes. Mol Cell Probes 1993; 7: 235-239. PMID: 8366869
55. Losekoot M, van Belzen MJ, Seneca S, Bauer P, Stenhouse SA, Barton DE, et al. EMQN/CMGS best practice guidelines for the molecular genetic testing of Huntington disease. Eur J Hum Genet. 2013; 21: 480-486 doi: 10.1038/ejhg.2012.200 PMID: 22990145
56. Livak JK, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001; 25: 402-408. PMID: 11846609
57. Lakatta EG. Cardiovascular ageing in health sets the stage for cardiovascular disease. Heart Lung Circ. 2002; 11: 76-91. PMID: 16352074
58. Besse S, Assayag P, Delcayre C, Carre F, Cheav SL, Lecarpentier Y, et al. Normal and hypertrophied senescent rat heart: mechanical and molecular characteristics. Am J Physiol. 1993; 265: H183-190. PMID: 8342633
59. Guo KK, Ren J. Cardiac overexpression of alcohol dehydrogenase (ADH) alleviates aging-associated cardiomyocyte contractile dysfunction: role of intracellular Ca2+ cycling proteins. Aging Cell 2006; 5: 259-265 PMID: 16842498
60. Marian MJ, Mukhopadhyay P, Borchman D, Tang D, Paterson CA. Regulation of sarco/endoplasmic and plasma membrane calcium ATPase gene expression by calcium in cultured human lens epithelial cells. Cell Calcium 2007; 41: 87-95. PMID: 16875731
61. Di Leva F, Domi T, Fedrizzi L, Lim D, Carafoli E. The plasma membrane Ca2+ ATPase of animal cells: structure, function and regulation. Arch Biochem Biophys 2008; 476: 65-74. doi: 10.1016/j.abb.2008.02.026 PMID: 18328800
62. Benn CL, Sun T, Sadri-Vakili G, McFarland KN, DiRocco DP, Yohrling GJ, et al. Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner. The Journal of Neurosciences 2008; 28(42): 10720-10733. doi: 10.1523/JNEUROSCI.2126-08.2008 PMID: 18923047